Outside United States Brands
DURASEAL™ DURAL
SEALANT SYSTEM
DURASEAL XACT™ ADHESION
BARRIER AND SEALANT SYSTEM
PLEURASEAL™ LUNG
SEALANT SYSTEM
SPRAYSHIELD™ ADHESION
BARRIER SYSTEM
Calendar Case Reports Webinars/OR Live Programs Publications & White Papers More about SprayShield™ ABOUT US CONTACT US
Click below to read more research and studies involving the SprayShield™ adhesion barrier system.
Publications
Title Authors Reference info
Pre-Clinical Evaluation of a Next-Generation Spray Adhesion Barrier for Multiple Site Adhesion Protection R. Ferland, MD;
P.K. Campbell, PhD
Surgical Technologies International. 2009;18:137-143.
White Papers
Title Authors PDF
Safety Requirements for Abdominopelvic Adhesion Barriers: Part No. 389123 SS* P.K. Campbell, PhD;
K. Howk

White Paper
Adhesion Prevention in General Surgery: A Next-Generation PEG Based Adhesion Barrier: Part No. 38912* R. Ferland, MD;
K. Howk;
P.K. Campbell, PhD

White Paper
Evaluation of SprayShield™ Adhesion Barrier System in a Porcine Model of Gynecological Surgery: Part No. 38911* R. Ferland, MD;
P.K. Campbell, PhD

White Paper
Technology Review of a Next-Generation Abdominopelvic Adhesion Barrier: Part No. 38912* Patrick K. Campbell, PhD;
Steven L Bennett, PhD

White Paper
The Adherence, Absorption Kinetics and Tissue Response of SprayShield™ Adhesion Barrier: Part No. 389121* Patrick K. Campbell, PhD;
Steven L Bennett, PhD;
David S. Garlick, DVM

White Paper
The Sprayshield™ Adhesion Barrier System Market Introduction: Clinical Trial Scenarios, Challenges, & Prospects: Part No. 05.09 LT-6000-062 Multiple
White Paper
* The author(s) of this paper received funding from Covidien to compensate him/her for the work performed in connection with the study discussed in the article.
This product is not FDA approved for the US Market.
COVIDIEN, COVIDIEN with logo, Covidien logo and positive results for life are U.S. and/or internationally registered trademarks of Covidien AG. Other ™ marked brands are trademarks of a Covidien company. © 2010 Covidien. All rights reserved.